RaySearch Laboratories AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSLBF research report →
About the company
RaySearch Laboratories AB (publ) is a global medical technology innovator, dedicated to developing advanced software solutions for cancer treatment. Its flagship product, RayStation, serves as a comprehensive treatment planning platform, integrating sophisticated features such as automated planning, adaptive therapy, multi-criteria optimization, and machine learning. This system ensures swift and precise dose calculations, minimizes exposure to organs-at-risk, and accommodates a wide spectrum of radiation modalities, from cutting-edge proton, carbon ion, and boron neutron capture therapies to conventional VMAT, IMRT, 3D-CRT, virtual simulation, electron beam, stereotactic, and tomotherapy treatments.
- CEO
- Johan Lof
- IPO
- 2015
- Employees
- 416
- HQ
- Stockholm, SE
Price Chart
- Market Cap
- $717.72M
- P/E
- 35.54
- P/S
- 6.05
- P/B
- 7.64
- EV/EBITDA
- 18.39
- Div Yield
- 1.72%
- Gross Margin
- 81.36%
- Op Margin
- 21.58%
- Net Margin
- 17.21%
- ROE
- 23.62%
- ROIC
- 14.35%
- Revenue
- $1.34B · 12.77%
- Net Income
- $227.80M · 11.93%
- EPS
- $6.65 · 11.95%
- Op Income
- $292.30M
- FCF YoY
- -40.64%
- 52W High
- $37.36
- 52W Low
- $19.57
- 50D MA
- $23.55
- 200D MA
- $24.77
- Beta
- 0.94
- Avg Volume
- 67
Get TickerSpark's AI analysis on RSLBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RSLBF coverage
Recent articles, reports, and earnings notes.
No research on RSLBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RSLBF report →Similar companies
Peers in the same neighborhood.